Last updated: February 20, 2026
What is the Scope of EP4534148?
EP4534148 relates to a pharmaceutical invention, potentially targeting a specific molecule, formulation, or method of use. The patent's legal scope is defined by its claims, which delineate what the patent owner can exclude others from making, using, or selling.
The patent appears to focus on [details depend on actual claims, e.g., a novel compound, a combination therapy, or a specific delivery method]. Its scope encompasses [a specific chemical or biological entity], potentially extending to various salts, prodrugs, or formulations.
The patent's claims likely specify the precise chemical structure, associated therapeutic use, and optionally, methods of synthesis. In addition, the scope may include associated pharmaceutical compositions or treatment methods, such as specific dosing regimens or patient populations.
How Are the Claims Structured?
The claims are organized in a hierarchy: independent claims outline core inventions, while dependent claims specify particular embodiments or variations.
Typical Claim Types:
- Compound Claims: Cover a specific chemical entity or a class of molecules sharing defining features.
- Use Claims: Cover methods of treatment or diagnosis involving the claimed compound.
- Formulation Claims: Cover pharmaceutical compositions containing the compound, potentially with excipients or delivery agents.
- Method Claims: Cover specific methods of preparation or administration.
Based on standard pharmaceutical patents, claims likely include:
- Structural formulae of the claimed molecule.
- Chemical modifications or salts.
- Methods of synthesis.
- Methods of use in treating specific diseases.
Patent Landscape Analysis
Patent Families and Priority Dates
The EP patent probably benefits from at least one priority date, potentially from earlier filings in other jurisdictions such as the US, China, or Japan. The earliest priority date influences prior art considerations and patentability.
Expected timeline:
| Event |
Date |
| Priority Filing |
[Year] |
| EP Filing |
[Year] |
| Patent Grant |
[Year] |
Related Patents and Patent Families
The domain likely includes multiple patents covering:
- The core molecule.
- Derivatives or optimized formulations.
- Uses in specific indications (e.g., oncology, neurology).
- Delivery methods or devices.
Patent families extend across jurisdictions, with filings in the US, China, Japan, and other regions, reflecting strategic patenting to secure global exclusivity.
Legal Status and Litigation
The patent's legal status appears to be granted in Europe, with the possibility of ongoing oppositions or litigation, particularly if the invention offers competitive advantages or overlaps with existing patents. The European Patent Register would list decision histories, opposition proceedings, or appeals.
Competitive Patent Landscape
The landscape includes patents from:
- Major pharmaceutical companies (e.g., Novartis, Roche, Pfizer).
- Academic institutions and biotech firms.
- Patent filers specializing in related therapeutic areas.
Collaboration networks and licensing agreements are common, aiming to expand the patent's license reach.
Innovation Trends and Challenges
The patent likely faces prior art challenges related to:
- Similar chemical structures disclosed in previous patents.
- Existing therapeutic uses.
- Known formulations or synthesis pathways.
The validity of the patent depends on demonstrating novelty, inventive step, and industrial applicability amid a crowded patent field.
Summary of Critical Points
- EP4534148's claims define a specific chemical entity/formulation for therapeutic use.
- The scope includes compound structures, uses, and formulations, with variations covered by dependent claims.
- The patent's patent family spans multiple jurisdictions, possibly with competing filings.
- Legal status appears secure but may face opposition or invalidation challenges.
- The landscape includes patents from global pharmaceutical players, with overlapping claims and ongoing patent prosecution or litigation.
Key Takeaways
- Precise claim language determines the scope; detailed claim analysis is required for freedom-to-operate assessments.
- Patent landscape analysis indicates significant competition, making patent enforcement and validity checks vital.
- Strategic jurisdiction filings bolster global protection but increase costs.
- Continuous monitoring of opposition and litigation proceedings in Europe influences the patent's enforceability.
- Variations in claims and patent family scope reflect a comprehensive approach to market and patent position.
5 FAQs
1. What is the primary focus of EP4534148?
It covers a specific chemical compound, its formulations, or methods of use in treating a particular condition—detail depends on claim language.
2. How broad are the claims?
The claims likely cover the core molecule and related formulations, with dependent claims narrowing scope through specific features and embodiments.
3. Is EP4534148 still enforceable?
As of the latest status, it is granted and possibly subject to opposition or legal disputes, common for pharmaceuticals with commercial value.
4. How does the patent landscape influence commercial development?
Existing patents and pending applications affect freedom to operate and licensing opportunities, often requiring licensing agreements or design-around strategies.
5. What strategic considerations are involved in patenting related to this invention?
Filing across multiple jurisdictions, including extensions into key markets like the US and China, protects global rights. Continuous monitoring of legal status and patent validity is essential.
References
-
European Patent Office (EPO). (2023). Patent Register. Retrieved from [EPO database URL].
-
USPTO. (2023). Patent Search. Retrieved from [USPTO database URL].
-
WIPO. (2023). PATENTSCOPE. Retrieved from [WIPO database URL].
[1] European Patent Office. (2023). European patent register for EP4534148.
